Screening for colorectal cancer (CRC) is effective in reducing CRC related mortality. Current
screening methods include endoscopy based and biomarker based approaches. This …

Objective Since the publication of the first Asia Pacific Consensus on Colorectal Cancer
(CRC) in 2008, there are substantial advancements in the science and experience of …

Background Early detection of pre-cancerous adenomas through screening can reduce
colorectal cancer (CRC) incidence. Fecal immunochemical tests are commonly used, but …

Background: Colorectal cancer (CRC) is the second most common cause of cancer-related
death (9.4% of the 9.9 million cancer deaths). However, CRC develops slowly, and early …

Colorectal cancer (CRC) is a global problem affecting millions of people worldwide. This
disease is unique because of its slow progress that makes it preventable and often curable …

Objective New screening tests for colorectal cancer (CRC) are rapidly emerging. Conducting
trials with mortality reduction as the end point supporting their adoption is challenging. We re …

Colorectal cancer (CRC) is the third most common cause of cancer death in men and
women in the United States. The main goals of screening are to prevent carcinogenesis (via …

Colorectal cancer (CRC) screening, the decade's most promising cancer-related public
health development, is evolving. Faecal immunochemical tests (FIT) will be the primary …

Introduction Colorectal cancer (CRC) is the second leading cause of cancer-related deaths
globally. Nonetheless, with early detection of CRC or its precancerous lesions, mortality, and …

Screening for colorectal cancer (CRC) and its precursor lesions, advanced adenomas (AA),
has been shown to effectively reduce CRC-related mortality. However, the method of CRC …